The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on August 7, 2026

Aug. 7, 2026

OffiGo Shares a Home Office Standing Desk Comparison Focused on Complete Workstation Planning

Indeterminate EIN Presswire

Aug. 7, 2026

Delesign Honored With WSI Supplier Excellence Award for Service to Global Agency Network

Indeterminate EIN Presswire

Aug. 7, 2026

Second Annual Open Atlas Summit to Convene High-Skilled Immigrants, Founders, Investors and Students in Silicon Valley

Indeterminate EIN Presswire

Aug. 7, 2026

Eyedaptic Announces Positive Clinical Results Presented at American Retina Forum National Meeting

Indeterminate EIN Presswire

Aug. 7, 2026

Pervaziv AI Debuts Cortex Router as the Eighth Model in Its Specialized AI Ensemble

Indeterminate EIN Presswire

Aug. 7, 2026

Eltropy Releases New Playbook Outlining a Four-Stage AI Framework for Community Financial Institutions

Indeterminate EIN Presswire

Aug. 7, 2026

Five Reputable Rollable LED Screen Manufacturers in China 2026: Pioneering Flexible Display Innovation

Indeterminate EIN Presswire

Aug. 7, 2026

AI/R lança plataforma unificada para governança de IA corporativa

Indeterminate GlobeNewswire

Aug. 7, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 7, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire

Aug. 7, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Aeries Technology to Report Financial Results for the Quarter Ended June 30, 2026 on August 10, 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

QCI AGI56.1 Now Deployed to Customers Following Successful Rollout

Indeterminate GlobeNewswire